Efficacy of Paroxetine (7.5 mg) in the treatment of menopause-associated vasomotor symptoms

被引：0
|
作者：
Belardo, Maria A. [1 ]
机构：
[1] Italian Hosp, Climacter Sect, Buenos Aires, DF, Argentina
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2019年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-4
引用
收藏
页码：1459 / 1459
页数：1
相关论文
共 50 条
  • [21] Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials
    Simon, James A.
    Portman, David J.
    Kaunitz, Andrew M.
    Mekonnen, Hana
    Kazempour, Kazem
    Bhaskar, Sailaja
    Lippman, Joel
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2013, 20 (10): : 1027 - 1035
  • [22] Paroxetine 7.5 mg Reduces Daily Frequency and Severity of Vasomotor Symptoms (VMS) Associated With Menopause: Results From 2 Multicenter, Randomized, Double-blind, Controlled Phase 3 Studies
    Kazempour, Kazem
    Bhaskar, Sailaja
    Mekonnen, Hana
    Lippman, Joel
    Kaunitz, Andrew M.
    Pinkerton, Joann
    [J]. JOURNAL OF WOMENS HEALTH, 2014, 23 (04) : 17 - 17
  • [23] Vasomotor symptoms in menopause - diagnostic and treatment
    Sobstyl, Malgorzata
    Bednarek, Wieslawa
    Tkaczuk-Wlach, Joanna
    Sobsty, Jacek
    Jakiel, Grzegorz
    [J]. MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2011, 10 (03): : 254 - 258
  • [24] Exercise for Treatment of the Vasomotor Symptoms of Menopause
    Fogleman, Corey D.
    [J]. AMERICAN FAMILY PHYSICIAN, 2012, 85 (03) : 237 - 237
  • [25] Critical appraisal of paroxetine for the treatment of vasomotor symptoms
    Carroll, Dana G.
    Lisenby, Katelin M.
    Carter, Tracy L.
    [J]. INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2015, 7 : 615 - 624
  • [26] Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms
    Stovall, Dale W.
    Pinkerton, Joann V.
    [J]. WOMENS HEALTH, 2008, 4 (03) : 257 - 268
  • [27] Effect of Body Mass Index on Treatment of Vasomotor Symptoms Associated with Menopause
    Ackerman, Ronald T.
    Hedrick, Richard E.
    Goracke-Postle, Cory
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1211 - 1212
  • [28] NAMS releases position statement on the treatment of vasomotor symptoms associated with menopause
    Neff, MJ
    [J]. AMERICAN FAMILY PHYSICIAN, 2004, 70 (02) : 393 - +
  • [29] Fezolinetant in the treatment of vasomotor symptoms associated with menopause: a profile of its use
    Blair, Hannah A.
    [J]. DRUGS & THERAPY PERSPECTIVES, 2024, 40 (05) : 173 - 180
  • [30] Efficacy and safety of fezolinetant in moderate-to-severe vasomotor symptoms associated with menopause
    Santoro, Nanette
    Johnson, Kimball
    Nappi, Rossella E.
    Neal-Perry, Genevieve
    Shapiro, Marla
    Stute, Petra
    Thurston, Rebecca C.
    Wolfman, Wendy
    English, Marci
    Franklin, Catherine
    Lee, Misun
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 129 : 154 - 155
12345